drugset / Trial / NCT01950260

Early Levothyroxine Post Radioactive Iodine

NCT01950260

Phase 2/3 Completed 61 enrolled Mayo Clinic
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The study will try to answer the question of whether early treatment with levothyroxine at 4 weeks after radioactive iodine for Graves'disease will prevent overt hypothyroidism (low thyroid hormone levels).

Timeline

Start
2013-09
Primary completion
2017-04
Completion
2017-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Levothyroxine Other / unclassified 50 ug

Indications